[
    "\u2003CGA\u2003AUC\u2003CUA\u2003AACCUC\u2003A SEQ\u2003ID\u2003NO:\u200312UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG346-364SG22525.9CUU\u2003GCA\u2003CGA\u2003AUC\u2003CUA\u2003AACCUC\u2003A SEQ\u2003ID\u2003NO:\u200313UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG346-364SG22650.4CUU\u2003GCA\u2003CGA\u2003AUC\u2003CUA\u2003AACCUC\u2003A SEQ\u2003ID\u2003NO:\u200314UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG346-364SG119(92.0)CAC\u2003GAA\u2003UCC\u2003UAA\u2003ACC\u2003UCA SEQ\u2003ID\u2003NO:\u200315UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG346-364SG235(3.1)CAC\u2003GAA\u2003UCC\u2003UAA\u2003ACC\u2003UCA SEQ\u2003ID\u2003NO:\u200316UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG346-364SG236(6.0)CAC\u2003GAA\u2003UCC\u2003UAA\u2003ACC\u2003UCA SEQ\u2003ID\u2003NO:\u200317AUU\u2003CGU\u2003GCU\u2003CAU\u2003GGU\u2003GCA335-353SG11823.8CUU\u2003GUG\u2003CAC\u2003CAU\u2003GAG\u2003CACGAA\u2003UUU SEQ\u2003ID\u2003NO:\u200318AUU\u2003CGU\u2003GCU\u2003CAU\u2003GGU\u2003GCA335-353SG21827.7CUU\u2003GUG\u2003CAC\u2003CAU\u2003GAG\u2003CACGAA\u2003U SEQ\u2003ID\u2003NO:\u200319AUU\u2003CGU\u2003GCU\u2003CAU\u2003GGU\u2003GCA335-353SG237(26)CUU\u2003GUG\u2003CAC\u2003CAU\u2003GAG\u2003CACGAA\u2003Utt SEQ\u2003ID\u2003NO:\u200320UUU\u2003UUC\u2003UUU\u2003GAG\u2003GUU\u2003UAG354-372SG10811.7GUU\u2003CCU\u2003AAA\u2003CCU\u2003CAA\u2003AGAAAA\u2003AUU SEQ\u2003ID\u2003NO:\u200321UUU\u2003UUC\u2003UUU\u2003GAG\u2003GUU\u2003UAG354-372SG219138.3GUU\u2003CCU\u2003AAA\u2003CCU\u2003CAA\u2003AGAAAA\u2003A SEQ\u2003ID\u2003NO:\u200322AUU\u2003CGU\u2003GCU\u2003CAU\u2003GGU\u2003GCA346-364SG239(58)CUU\u2003GUG\u2003CAC\u2003CAU\u2003GAG\u2003CACGAA\u2003Utt SEQ\u2003ID\u2003NO:\u200323AUU\u2003CGU\u2003GCU\u2003CAU\u2003GGU\u2003GCA346-364SG240(39)CUU\u2003GUG\u2003CAC\u2003CAU\u2003GAG\u2003CACGAA\u2003Utt SEQ\u2003ID\u2003NO:\u200324AUU\u2003CGU\u2003GCU\u2003CAU\u2003GGU\u2003GCA346-364SG241(27)CUU\u2003GUG\u2003CAC\u2003CAU\u2003GAG\u2003CACGAA\u2003Utt SEQ\u2003ID\u2003NO:\u200352UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG346-364SG242CUU\u2003GCA\u2003CGA\u2003AUC\u2003CUA\u2003AACCUC\u2003A SEQ\u2003ID\u2003NO:\u200353UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU346-364SG243GCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200354CGU\u2003GCU\u2003UAG\u2003GAU\u2003UUG\u2003GAG\u2003UUUN/ASG221ACU\u2003CCA\u2003AAU\u2003CCU\u2003AAG\u2003CAC\u2003G(c)Note:The shRNAs were tested in several experiments. Where there were different IC<sub>50 </sub>values in different experiments, the range of the IC<sub>50 </sub>values is shown.( ): Estimated IC50.</p>Example 3: Activity of R sshRNAs is not Affected by 2%0-Methyl Modification of the Antisense SequenceIn contrast to L sshRNA, when the loop was placed at the 3\u2032 end of the sense sequence (R sshRNA), the sshRNA with the same modification pattern (second nucleotide on the antisense sequence and alternating nucleotide on the sense sequence, SG233) proved to be as effective as the unmodified (FIG. 3D).</p>The sequences of these shRNAs are shown in Table 3. Nucleotides forming the shRNA loops and 3\u2032 overhangs are shown in bold. Nucleotides with 2\u2032-O-Methyl modification are underlined.</p>TABLE\u20033shRNA\u2003sequences\u2003used\u2003in\u2003Example\u20033TargetpositionSequenceonshRNAIC<sub>50</sub>ID#Sequence\u2003(5\u2032-3\u2032)IRESabbrev(pM)SEQ\u2003IDGCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC346-364SG68\u200333.7NO:\u200325ACA\u2003AUA\u2003UGA\u2003GGU\u2003UUA\u2003GGAUUC\u2003GUG\u2003CUUSEQ\u2003IDGCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC346-364SG231(40.2)NO:\u200326ACA\u2003AUA\u2003UGA\u2003GGU\u2003UUA\u2003GGAUUC\u2003GUG\u2003CUU SEQ\u2003IDGCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC346-364SG233(55.5)NO:\u200327ACA\u2003AUA\u2003UGA\u2003GGU\u2003UUA\u2003GGAUUC\u2003GUG\u2003CUU SEQ\u2003IDGCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC346-364SG232\u2014NO:\u200328ACA\u2003AUA\u2003UGA\u2003GGU\u2003UUA\u2003GGAUUC\u2003GUG\u2003CUU( ): Estimated IC50</p>Example 4: Phosphorothioate Bonds at the Open End of the Duplex do not Affect the Activity of sshRNAsExonucleases comprise the primary class of nucleases present in mammalian serum. We tested whether the addition of phosphorothioate bonds in the 5\u2032-end of the antisense sequence and 3\u2032-end of the sense sequence will affect the efficacy of L sshRNAs (SG211, FIG. 4). Compared to the unmodified molecule SG105, no RNAi activity loss was found with SG211. The addition of alternating 2\u2032-OMe substitution in the sense sequence also did not affect the potency of the PS modified sshRNA (SG212).</p>The sequences of these shRNAs are shown in Table 4. Nucleotides forming the shRNA loops and 3\u2032 overhangs are shown in bold. Nucleotides with 2\u2032-O-Methyl modification are underlined. Deoxyribonucleotides are indicated by lower-case letters. Phosphorothioate bonds are indicated by *.</p>TABLE\u20034shRNA\u2003sequences\u2003used\u2003in\u2003Example\u20034TargetSequencepositionshRNAIC<sub>50</sub>ID#Sequence\u2003(5\u2032-3\u2032)on\u2003IRESabbrev(pM)SEQ\u2003IDUGA\u2003GGU\u2003UUA\u2003GGA346-364SG1052.3-3.5NO:\u20031UUC\u2003GUG\u2003CUU\u2003GCACGA\u2003AUC\u2003CUA\u2003AACCUC\u2003A SEQ\u2003IDU*G*A\u2003GGU\u2003UUA\u2003GGA346-364SG2113.0NO:\u200329UUC\u2003GUG\u2003CUU\u2003GCACGA\u2003AUC\u2003CUA\u2003AACCU*C*\u2003A SEQ\u2003ID\u2003U*G*A\u2003GGU\u2003UUA\u2003GGA346-364SG2123.7NO:\u200330UUC\u2003GUG\u2003Ctt\u2003GCACGA\u2003AUC\u2003CUA\u2003AACCU*C*\u2003A</p>Example 5: Effect of End Conjugations on the Activity of sshRNAsEnd conjugation, such as with cholesterol or alpha-tocopherol, has been shown to facilitate in vivo delivery of siRNAs to the liver (Soutschek et al. 2004; Nishina et al. 2008). Oth",
    "nd of the L sshRNA and the 5\u2032 phosphate is essential for binding to Dicer and/or Ago2 in RISC, the loss of RNAi activity by replacing the 5\u2032 phosphate may not seem surprising. A similar phenomenon was observed with siRNAs when conjugation occurred at the 5\u2032 end of the antisense sequence. R sshRNAs were also tested for the influence of end conjugation on their activities. Unlike with L sshRNAs, 5\u2032-end conjugation (at the 5\u2032-end of the sense sequence) of R sshRNAs did not significantly affect efficacy, whereas 3\u2032-end conjugation (at 3\u2032-end of the antisense sequence) reduced the potency of these R sshRNAs (FIG. 5B).</p>The sequences of these shRNAs are shown in Table 5. Nucleotides bearing the shRNA loops and 3\u2032 overhangs are shown in bold. Deoxyribonucleotides are indicated by lower-case letters. Phosphorothioate bonds are indicated by *.</p>TABLE\u20035\u2003shRNA\u2003sequences\u2003used\u2003in\u2003Example\u20035TargetpositionSequenceonshRNAIC<sub>50</sub>ID#Sequence\u2003(5\u2032-3\u2032)IRESabbrev(pM)SEQ\u2003IDUGA\u2003GGU\u2003UUA\u2003GGA346-364SG1057.7NO:\u20031UUC\u2003GUG\u2003CUU\u2003GCACGA\u2003AUC\u2003CUA\u2003AACCUC\u2003A SEQ\u2003IDS-S-C6-UGA\u2003GGU346-364SG1438159.8NO:\u200331UUA\u2003GGA\u2003UUC\u2003GUGCUU\u2003GCA\u2003CGA\u2003AUCCUA\u2003AAC\u2003CUC\u2003ASEQ\u2003IDUGA\u2003GGU\u2003UUA\u2003GGA346-364SG1444.8NO:\u200332UUC\u2003GUG\u2003CUU\u2003GCACGA\u2003AUC\u2003CUA\u2003AACCUC\u2003A-C3-S-S SEQ\u2003IDGCA\u2003CGA\u2003AUC\u2003CUA346-364SG68\u200333.7NO:\u200325AAC\u2003CUC\u2003ACA\u2003AUAUGA\u2003GGU\u2003UUA\u2003GGAUUC\u2003GUG\u2003CUU SEQ\u2003IDC3-GCA\u2003CGA\u2003AUC346-364SG146(115.0)NO:\u200333CUA\u2003AAC\u2003CUC\u2003ACAAUA\u2003UGA\u2003GGU\u2003UUAGGA\u2003UUC\u2003GUG\u2003CUU SEQ\u2003IDGCA\u2003CGA\u2003AUC\u2003CUA346-364SG147(400.0)NO:\u200334AAC\u2003CUC\u2003ACA\u2003AUAUGA\u2003GGU\u2003UUA\u2003GGAUUC\u2003GUG\u2003CUU-C3( ): Estimated IC50</p>Example 6: The Effect of Modified Loop on the Activity of sshRNAsModifications in the loop were examined for both R and L sshRNAs. As shown in FIG. 6A, the loop of the L sshRNAs could be substituted with deoxynucleotides (SG209) without an activity loss. This is also true when phosphorothioate linkages were added into a loop that contains DNA (SG210, FIG. 6A). However, reduced efficacy was seen when phosphorothioate (PS) linkages and DNA were placed in the loop of R sshRNA, but not when PS bonds and RNA were in the loop (SG234 in FIG. 6B and SG223 in FIG. 6C).</p>L and R sshRNAs with modified loops that contain uncleavable linkers such as non-nucleotidic linkers (SG229 and SG228) were also tested for their target knockdown activities. As shown in FIG. 6C, none of these loop modifications significantly affected the potency of L or R sshRNAs. Since nonnucleotidic linkers, deoxynucleotides, and phosphorothioate bonds block the cleavage by RNases such as Dicer, the results suggest that cleavage at certain position in the loop is required for the activity of R sshRNA but not for L sshRNA.</p>The sequences of these shRNAs are shown in Table 6. Nucleotides forming the shRNA loops and 3\u2032 overhangs are shown in bold. Deoxyribonucleotides are indicated by lower-case letters. Phosphorothioate bonds are indicated by *.</p>TABLE\u20036shRNA\u2003sequences\u2003used\u2003in\u2003Example\u20036TargetpositionshRNAIC<sub>50</sub>Sequence\u2003ID#Sequence\u2003(5\u2032-3\u2032)on\u2003IRESabbrev(pM)SEQ\u2003ID\u2003NO:\u20031UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU346-364SG1053.7GCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200335UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003Ctt346-364SG2096.6GCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200336UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG*\u2003c*t*t*346-364SG2106.2g*CA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200337UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG346-364SG2291.4CC3C3\u2003GCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUCA SEQ\u2003ID\u2003NO:\u200325GCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003ACA346-364SG68\u200333.7AUA\u2003UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUGCUU SEQ\u2003ID\u2003NO:\u200338GCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003ACA346-364SG22857.1C3C3A\u2003UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUCGUG\u2003CUU SEQ\u2003ID\u2003NO:\u200339GCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003A*C*A*346-364SG22320.5A*U*A*\u2003UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUCGUG\u2003CUU SEQ\u2003ID\u2003NO:\u200340GCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003A*c*a*346-364SG234(710.0)a*t*a*\u2003UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUGCUU( ): Estimated IC50</p>Example 7: 2\u2032-OMe Modification can Improve the Serum Stability of sshRNAsAlthough dsRNAs are more stable than single-stranded RNAs (ssRNAs), sshRNAs without chemical modification are still very sensitive to nucleases. sshRNAs (3.35 \u03bcg) were incubated with 10% human serum (Sigma, St Louis, Mo.) in PBS at 37\u00b0 C. An aliquot of was taken out at each time point and was immediately mixed with 2\u00d7 gel loading buffer (Ambion, Austin, Tex.) and stored at \u221280\u00b0 C. Subsequent gel electrophoresis of the samples was performed under denaturing condition: 12% polyacrylamide, 20% formamide, and 8M urea. The gel was stained with SYBR Gold (Invitrogen). As shown in FIG. 7A, the majority of the naked sshRNA with a 5-nt loop (SG68) was degraded within 5 minutes upon incubation in 10% human serum at 37\u00b0 C. Faint bands with sizes around 20 to 30 nucleotides were detected in denaturing polyacrylamide gels, suggesting that the loop of the hairpin may be the most vulnerable region for serum nucleases. Interestingly, an sshRNA with 2-nt UU loop and no 3\u2032 overhang (SG105) was stable up to 2 hours of incubation in human serum. This suggests that shRNAs with small loops may be generally more resistant to nucleases. With 2\u2032-O-Me modification at alternating nucleotides in the sense sequence and each nucleotide in the loop, the molecule remained largely intact for up to 6 to 12 hours (FIG. 7A). When 2\u2032-O-Me modification was extended both into position 17 of the guide strand (SG242) and positions 15 an",
    " the sense sequence significantly reduced but not completely removed the activity of R sshRNA (SG148, FIG. 9C). These results suggest that the processing of R sshRNA is probably different from that of L sshRNA.</p>The sequences of these shRNAs are shown in Table 14. Nucleotides forming the shRNA loops and 3\u2032 overhangs are shown in bold. Deoxyribonucleotides are indicated by lower-case letters. Phosphorothioate bonds are indicated by *. Mismatches made at the sense sequence is shown in Italic.</p>TABLE\u200314Listing\u2003of\u2003shRNA\u2003Sequences\u2003Targeting\u2003HCV\u2003IRES\u2003Used\u2003in\u2003Example\u200311.TargetpositionshRNAIC<sub>50</sub>Sequence\u2003ID#Sequence\u2003(5\u2032-3\u2032)on\u2003IRESabbrev(pM)*SEQ\u2003ID\u2003NO:\u20031UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU\u2003GCA346-364SG1053.5CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200343UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU\u2003GCA346-364SG2132.3CG*A*\u2003A*UC\u2003CUA\u2003AAC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200344UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU\u2003GCA346-364SG2149.8CGA\u2003AU*G*\u2003C*UA\u2003AAC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200345UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU\u2003GCA346-364SG2155.7CGA\u2003AUC\u2003CU*A*\u2003A*AC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200346UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU\u2003GCA346-364SG22272.8CGA\u2003AUC*\u2003CUA\u2003AAC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200348UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU\u2003GCA346-364SG145N/ACGA\u2003ACA\u2003AGA\u2003AAC\u2003CUC\u2003A SEQ\u2003ID\u2003NO:\u200349UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU\u2003gca346-364SG227N/Acga\u2003atc\u2003cta\u2003aac\u2003ctc\u2003a SEQ\u2003ID\u2003NO:\u200325GCA\u2003CGA\u2003AUC\u2003CUA\u2003AAC\u2003CUC\u2003ACA\u2003AUA346-364SG68\u200333.7UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU SEQ\u2003ID\u2003NO:\u200350GCA\u2003CGA\u2003ACA\u2003AGA\u2003AAC\u2003CUC\u2003ACA\u2003AUA346-364SG148(1000)UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU SEQ\u2003ID\u2003NO:\u200351GCA\u2003CGA\u2003AUC*\u2003CUA\u2003AAC\u2003CUC\u2003ACA\u2003AUA346-364SG230(68.5)UGA\u2003GGU\u2003UUA\u2003GGA\u2003UUC\u2003GUG\u2003CUU*IC50 values are based on dose response curves generated in 293FT cells; those in parentheses are estimated, others are calculated as in Example 1.</p>Example 12: 2\u2032-O-Me-Modified sshRNAs are not Dicer Substrates In VitrosshRNAs can adapt both monomeric hairpin and higher order multimer conformations (mainly dimers) in solution (FIG. 10, lanes labeled (\u2212)). When the sshRNAs are heated to 95\u00b0 C. for 4 minutes and quickly cooled in an ice bath (snap cooling), the multimeric sshRNAs are quantitatively converted to monomer hairpins (FIG. 10, lanes 105*(\u2212) and 224*(\u2212)). To examine whether 2\u2032-O-Me-modified sshRNA in either monomer or dimer form can be substrates for Dicer, we incubated SG224, which has alternating 2\u2032-O-Me modifications in the passenger strand and both uridine residues in the loop, with recombinant Dicer in vitro. In parallel, we performed in vitro Dicer cleavage reactions with SG105, a molecule with the same sequence as SG224 but lacking any 2\u2032-O-Me modifications. The dimer conformation of both SG105 and SG224 consists of two 19 bp duplexes surrounding two central U\u2014U mismatches. Both SG105 and SG224 monomer hairpins are not cleaved by dicer in vitro (FIG. 10, lanes 105*(+) and 224*(+)), which supports a dicer-independent mechanism for activity of sshRNAs. Although Dicer does not appear to be involved in processing monomer sshRNAs, the dimer conformation of SG105 can be cleaved by recombinant Dicer in vitro (FIG. 10, 105(+)). However, dimers of SG224 were found not "
]